{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:06:47Z","timestamp":1788174407183,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold><jats:italic>Pueraria lobata<\/jats:italic> is traditionally used in China for treatment of non-alcoholic fatty liver disease (NAFLD). Puerarin, a functional drug extracted from <jats:italic>Pueraria lobata<\/jats:italic>, features a pharmacological activity. The present study aims to investigate the effect of puerarin intervention on NAFLD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We established an NAFLD mouse model using a high-fat diet with 60% fat and evaluated the impact of puerarin intervention.<\/jats:p><jats:p><jats:bold>Results and discussion:<\/jats:bold> Our results demonstrate that puerarin intervention significantly ameliorates lipid accumulation and protects the liver from high-fat-induced damage while reducing oxidative stress levels in the liver. Furthermore, puerarin intervention significantly downregulates the transcription levels of acetyl-CoA carboxylase (ACC1) in the liver. It also upregulates the transcription levels of carnitine palmitoyltransferase 1 (CPT1), peroxisome proliferator-activated receptor alpha (PPAR\u03b1), and peroxisome proliferators-activated receptor \u03b3 coactivator alpha (PGC1\u03b1), which are related to oxidation. Furthermore, we demonstrated that flavin-containing monooxygenase (FMO5) was involved in the protective effect of puerarin against NFALD. In conclusion, the present study demonstrated the beneficial effect of puerarin on NAFLD and showed that puerarin could prevent liver injury and lipid accumulation caused by NAFLD via activating FMO5. These findings provide a new theoretical basis for applying puerarin as a therapeutic agent for NAFLD.<\/jats:p>","DOI":"10.3389\/fphar.2024.1423634","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:25:43Z","timestamp":1720671943000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhaoyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanglei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.redox.2014.02.008","article-title":"Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage","volume":"2","author":"Anuranjani","year":"2014","journal-title":"Redox Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci. (Lond)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1016\/s0024-3205(00)00885-7","article-title":"Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism","volume":"67","author":"Guerra","year":"2000","journal-title":"Life Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"587189","DOI":"10.3389\/fendo.2020.587189","article-title":"ChREBP-mediated regulation of lipid metabolism: involvement of the gut microbiota, liver, and adipose tissue","volume":"11","author":"Iizuka","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/nu9010033","article-title":"The root extract of Pueraria lobata and its main compound, puerarin, prevent obesity by increasing the energy metabolism in skeletal muscle","volume":"9","author":"Jung","year":"2017","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2022.08.037","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2\/NQO-1 pathway","volume":"192","author":"Kang","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13046-020-01782-w","article-title":"Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPAR\u03b1 to activate the NF-\u03baB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance","volume":"40","author":"Kong","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/molecules25173970","article-title":"Potential anti-diabetic activity of Pueraria lobata flower (flos puerariae) extracts","volume":"25","author":"Lertpatipanpong","year":"2020","journal-title":"Molecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00210-019-01708-0","article-title":"Spexin protects cardiomyocytes from hypoxia-induced metabolic and mitochondrial dysfunction","volume":"393","author":"Liu","year":"2020","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"155528","DOI":"10.1016\/j.metabol.2023.155528","article-title":"Targeting FABP4 in elderly mice rejuvenates liver metabolism and ameliorates aging-associated metabolic disorders","volume":"142","author":"Lv","year":"2023","journal-title":"Metabolism"},{"key":"B16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0286692","DOI":"10.1371\/journal.pone.0286692","article-title":"Metabolomic and transcriptomic analyses of Fmo5-\/- mice reveal roles for flavin-containing monooxygenase 5 (FMO5) in NRF2-mediated oxidative stress response, unfolded protein response, lipid homeostasis, and carbohydrate and one-carbon metabolism","volume":"18","author":"Phillips","year":"2023","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/lifemeta\/load050","article-title":"Hepatic TRPC3 loss contributes to chronic alcohol consumption-induced hepatic steatosis and liver injury in mice","volume":"3","author":"Qinchao","year":"2023","journal-title":"Life Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1124\/dmd.110.033639","article-title":"Characterization of human flavin-containing monooxygenase (FMO) 3 and FMO5 expressed as maltose-binding protein fusions","volume":"38","author":"Reddy","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"B24","doi-asserted-by":"publisher","first-page":"11138","DOI":"10.1074\/jbc.R117.779678","article-title":"Flavin-containing monooxygenases in aging and disease: emerging roles for ancient enzymes","volume":"292","author":"Rossner","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1467-789X.2009.00642.x","article-title":"Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome","volume":"11","author":"Schreurs","year":"2010","journal-title":"Obes. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1124\/dmd.117.076612","article-title":"Identification of flavin-containing monooxygenase 5 (FMO5) as a regulator of glucose homeostasis and a potential sensor of gut bacteria","volume":"45","author":"Scott","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"B28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.3390\/nu11112579","article-title":"Effect of high-fat diets on oxidative stress, cellular inflammatory response and cognitive function","volume":"11","author":"Tan","year":"2019","journal-title":"Nutrients"},{"key":"B30","doi-asserted-by":"publisher","first-page":"G987","DOI":"10.1152\/ajpgi.90272.2008","article-title":"Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent","volume":"295","author":"Tetri","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.7150\/thno.56157","article-title":"High fat diet, gut microbiome and gastrointestinal cancer","volume":"11","author":"Tong","year":"2021","journal-title":"Theranostics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/nu9101072","article-title":"Animal models of nonalcoholic fatty liver disease-A starter's guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"key":"B33","doi-asserted-by":"publisher","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"859681","DOI":"10.3389\/fphys.2022.859681","article-title":"Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5 (-\/-) mice, decreases plasma cholesterol and epididymal fat deposition","volume":"13","author":"Veeravalli","year":"2022","journal-title":"Front. Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1002\/ptr.6417","article-title":"Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1\/PI3K\/AKT signaling pathway and facilitating mitochondrial homeostasis","volume":"33","author":"Wang","year":"2019","journal-title":"Phytother. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12906-020-02962-z","article-title":"Genistein and exercise modulated lipid peroxidation and improved steatohepatitis in ovariectomized rats","volume":"20","author":"Witayavanitkul","year":"2020","journal-title":"BMC Complement. Med. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1039\/c8fo02375a","article-title":"Polysaccharides derived from natural sources regulate triglyceride and cholesterol metabolism: a review of the mechanisms","volume":"10","author":"Wu","year":"2019","journal-title":"Food Funct."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.3390\/molecules28186577","article-title":"Advances in extraction, purification, and analysis techniques of the main components of kudzu root: a comprehensive review","volume":"28","author":"Xuan","year":"2023","journal-title":"Molecules"},{"key":"B39","doi-asserted-by":"publisher","first-page":"108138","DOI":"10.1016\/j.envint.2023.108138","article-title":"PPAR\u03b1\/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: an integrated approach","volume":"178","author":"Yang","year":"2023","journal-title":"Environ. Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1002\/jcp.29553","article-title":"Effects of different fatty acids on BRL3A rat liver cell damage","volume":"235","author":"Yang","year":"2020","journal-title":"J. Cell Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.7150\/ijbs.54604","article-title":"Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver","volume":"17","author":"Yu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"956688","DOI":"10.3389\/fimmu.2022.956688","article-title":"Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ptr.5083","article-title":"Puerarin: a review of pharmacological effects","volume":"28","author":"Zhou","year":"2014","journal-title":"Phytother. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10940","DOI":"10.3390\/ijms222010940","article-title":"Exercise intervention mitigates pathological liver changes in NAFLD zebrafish by activating SIRT1\/AMPK\/NRF2 signaling","volume":"22","author":"Zou","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1423634\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:25:47Z","timestamp":1720671947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1423634\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":44,"alternative-id":["10.3389\/fphar.2024.1423634"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1423634","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"article-number":"1423634"}}